Myriad Genetics Announces Fourth Quarter and Year End Fiscal 2005 Financial Results Conference Call; Tuesday, August 23rd at 10:00 a.m. ET

SALT LAKE CITY--(BUSINESS WIRE)--Aug. 9, 2005--Myriad Genetics, Inc. (NASDAQ:MYGN) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc. and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

                         DATE: August 23, 2005
                           TIME: 10:00 am ET
                   DOMESTIC DIAL-IN: (888) 589-2820
                 INTERNATIONAL DIAL-IN: (706) 634-2173
               (Please dial in approximately 10 minutes
                before the call is scheduled to begin)

   A press release will be issued at 6:30 am ET on August 23, 2005.
  Replay of the call will be available from two hours after the call
 through August 30th by dialing (800) 642-1687 or (706) 645-9291, and
                entering conference ID number 8597788.

       A live audio Webcast will be available at: www.myriad.com

This call is being webcast by Thomson/CCBN and is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

    CONTACT: Myriad Genetics, Inc.
             Suzanne Barton, 801-584-1138

    SOURCE: Myriad Genetics, Inc.